Particle.news
Download on the App Store

Cochrane Review Finds Intermittent Fasting Offers No Weight-Loss Edge Over Standard Dieting

A pooled analysis of 22 trials reports only modest losses versus no‑diet controls.

Overview

  • Researchers synthesized 22 randomized trials involving 1,995 adults with overweight or obesity, tracking results for up to 12 months.
  • When compared with conventional energy-restricted plans, intermittent-fasting protocols produced similar weight loss with no meaningful advantage.
  • Against no‑diet controls, fasting groups lost roughly 3% to 3.5% of body weight on average, below the ~5% threshold often considered clinically meaningful.
  • The evidence base remains limited by small samples, short durations, inconsistent reporting, and overrepresentation of white participants in high‑income countries, with varied fasting methods studied.
  • Experts say fasting may still suit personal preference for some individuals, while calling for longer, larger, and more diverse trials that evaluate metabolic outcomes, adherence, lean‑mass changes, and potential harms.